TNF Pharmaceuticals (TNFA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TNFA TNF Pharmaceuticals

Watchlist

1.450
+0.220+17.89%

Close Dec 18 16:00 ET

1.490
+0.040+2.76%

Post 19:52 ET

3.99MMarket Cap-0.11P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Tnf Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
ReutersDec 9 09:00 ET
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
BusinesswireDec 9 09:00 ET
TNF Pharmaceuticals Announces New Board and Shareholder Votes
TipRanksNov 26 08:28 ET
TNF Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
SECNov 14 17:08 ET · Announcements
Eagle EGRX Delist; TNF Pharmaceuticals TNFA Equity Investment
BioPharmCatalystOct 2 14:01 ET
Express News | Tnf Pharmaceuticals Inc - Fully Funded for Clinical Trials for Next Two Years
ReutersOct 2 09:10 ET

Comments

Stock_Drift

Dec 9 10:18

Low Floats 12:17pm

$Streamline Health Solutions (STRM.US)$ $China SXT Pharmaceuticals (SXTC.US)$ $TNF Pharmaceuticals (TNFA.US)$ $Versus Systems (VS.US)$ $XChange TEC (XHG.US)$ $Senti Biosciences (SNTI.US)$ $Iveda Solutions (IVDA.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Sonnet BioTherapeutic (SONN.US)$ $Gaxos.ai (GXAI.US)$ $Zeo Energy (ZEO.US)$ $Asset Entities (ASST.US)$
📊⚡️📊

Trytosaveabit

Dec 9 08:04

Update

$TNF Pharmaceuticals (TNFA.US)$ Reuters· 3 mins ago
Tnf Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Trytosaveabit

Oct 2 08:11

Update

$TNF Pharmaceuticals (TNFA.US)$ TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
1 MINUTE AGO, 9:10 AM EDT
VIA BUSINESSWIRE
Prevail Partners, LLC investment priced at more than a 40% premium to market
Prevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service CRO with hundreds of clinical trials over a decade
TNF Pharmaceuticals fully funded for clinical trials for next two years